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Background: According to the Developmental
Origins of Health and Disease (DOHaD) hy-
pothesis, several noncommunicable diseases,
including hypertension, type 2 diabetes, and cor-
onary heart disease, have their origins in early life.
Chronic kidney disease (CKD) has traditionally
been assumed to develop as the result of an
interaction between genetic and environmental
factors, although more recently, the importance of
factors present early in life has been recognized.
Study Design: Longitudinal birth cohort study.
Setting & Participants: 20,431 people born in
1924 to 1944 in Helsinki, Finland, who were part
of the Helsinki Birth Cohort Study were followed
up through their life course from birth until death
or age 86 years.
Predictor: Prenatal growth and socioeconomic
factors.
Outcomes: Death or hospitalization for CKD.Editorial, p. 3
0
Results: Smaller body size at birth was associ-
ated with increased risk for developing CKD.
Each standard deviation higher birth weight was
associated with an HR for CKD of 0.82 (95% CI,
0.74-0.91; P < 0.001). Associations with pon-
deral index at birth, placental weight, and birth
length were also statistically significant
(P < 0.001, P < 0.001, and P = 0.002, respec-
tively), but only among men. Prematurity also
predicted increased risk for CKD.
Limitations: The study was restricted to people
who were born in Helsinki in 1924 to 1944.
Conclusions: Smaller body size at birth was
associated with increased risk for developing
CKD in men. Prematurity was also associated
with increased risk for CKD in women. These
findings in the Helsinki Birth Cohort Study sup-
port the importance of early life factors in the
development of CKD.Globally, noncommunicable diseases cause moredeaths than communicable diseases, and chronic
kidney disease (CKD) is one important contributor to the
noncommunicable disease burden.1-3 Traditionally, CKDs
have been assumed to develop as the result of an interac-tion between genetic and environmental factors, although
the importance of factors active early in life has more
recently been recognized.4,5
According to the Developmental Origins of Health and
Disease (DOHaD) hypothesis, several noncommunicable
diseases, including hypertension, type 2 diabetes, and
coronary heart disease, have their origins in early life.6-9
This is believed to work through a process called devel-
opmental programming, and factors affecting renal
development during early life have been recognized as
being associated with increased risk for CKD.4,5,10
In the 1980s, Brenner et al11 proposed that intrauterine
growth restriction causes a low nephron number in the
kidneys. This hypothesis is based on the observation that
the number of nephrons is determined by term, with 60%
of nephrons formed during the third trimester, and that
regardless of possible deficits in nephron number, little if
any compensatory growth occurs after term birth. During
the life course, a low nephron number results in hyper-
filtration and subsequently sodium retention, salt-sensitive
hypertension, nephron loss, and CKD caused by secondary
focal segmental glomerulosclerosis.11,12 This has beenshown to be the case and studies have reported an asso-
ciation between low birth weight and CKD. However,
most previous studies have been rather small or have not
been able to follow up the study cohort until old age.13
Within the Helsinki Birth Cohort Study (HBCS), we
have followed up through the life course 20,431 people
born in 1924 to 1944. The aim of the present study was to
focus on prenatal programming of CKD, taking gestational
age, socioeconomic factors, and several neonatal charac-
teristics into account.Methods
Participants
The HBCS includes 2 birth cohorts. The older cohort of
7,086 people born in 1924 to 1933 at Helsinki University
Central Hospital, and who also went to school in the city,
has been described in greater detail previously.14 A younger
cohort is made up of 13,345 people born in 1934 to 1944
at Helsinki University Central Hospital or the Helsinki
City Maternity Hospital in Helsinki, Finland. These were the
only public hospitals operating in the city at the time.15
Measurements
Birth records from both cohorts include data for birth
weight, length at birth, head circumference, placental
weight, last menstrual period, and maternal age, height,
and weight before delivery. Ponderal index, defined as
weight divided by the cube of height, was calculated.
Gestational age at delivery was calculated from lastAJKD Vol 71 | Iss 1 | January 2018
Original Investigationmenstrual period dates. The birth records include infor-
mation for socioeconomic factors and paternal occupation.
These cohorts have been followed up longitudinally by
linkage to national Finnish registers, which provide in-
formation for both morbidity and mortality.15
Outcomes
We used data from the 20,431 individuals from both
cohorts of the HBCS. They all lived in Finland in 1971,
when a unique identification number was allocated to each
member of the Finnish population. Using this unique
identification number, we followed up individuals from
January 1, 1971, through December 31, 2010, by linking
their birth data to the Finnish National Death Register and
the national Care Register for Health Care (previously the
Hospital Discharge Register).
All hospital admissions in Finland are recorded in the
national Care Register for Health Care.16 All deaths are
recorded in the national Causes of Death Register.17 The
Death Register includes the date and cause of death,
coded according to International Classification of Diseases, Eighth
Revision (ICD-8) until the end of 1986, thereafter ICD, Ninth
Revision (ICD-9) until the end of 1996, and ICD, Tenth
Revision (ICD-10) from 1997 onward. Deaths from CKD
were identified via linkage to the Finnish National Death
Registry. All deaths are based on physician-written death
certificate data. Definition of CKD was according to the
diagnoses in Table S1 (provided as online supplementary
material).
The Care Register for Health Care is a continuation of
the Hospital Discharge Register, which has data for patients
discharged from hospitals in 1969 to 1993. The Hospital
Discharge Register was replaced with the Care Register for
Health Care as of 1994. The purpose of the register is to
collect data for the activities of health centers, hospitals,
and other institutions providing inpatient care and the
clients treated in them, as well as home nursing clients, for
the purposes of statistics, research, and planning. The
outcome variables used when assessing hospitalization for
CKD are itemized in Table S1 and are based on the di-
agnoses provided (ICD codes) by the treating physician as
the reasons for hospitalization.
In the present study, we used the combination of
hospitalization and death from CKD as an outcome in
order to optimize and maximize the number of individuals
with CKD. However, using this approach does not allow us
to capture the actual timing of onset of CKD.
We used the father’s occupation as an indicator of
childhood socioeconomic position, as described previ-
ously.18 Through Statistics Finland, we obtained data for
occupation from census data from 1970 to 2000.19We used
the maximum attained occupational status, grouped into
manual worker, self-employed, and lower or higher official.
Analytical Approach
We used a Cox proportional hazards model to analyze
the data. We always stratified the analysis usingAJKD Vol 71 | Iss 1 | January 2018combinations of sex and year of birth and always
included early-life and adult socioeconomic variables in
categories. We followed up each individual to the first of
the 5 following events: migration away from Finland,
death attributable to kidney disease, death from another
cause, hospitalization for kidney disease, and reaching
January 1, 2011, still alive. Either death or hospitaliza-
tion from kidney disease was taken as the outcome of
study. We tested the proportional hazards assumption by
comparing hazard ratios (HRs) in distinct age intervals
and explored differences in associations of neonatal
measures with kidney disease between men and women
by including interaction terms and among the 4 sub-
causes by setting up a 3-df χ2 test. To compare HRs
across subcauses, we used the standard test for hetero-
geneity in fixed-effects meta-analysis. We included
neonatal measurements in standardized form so that
their associations with risk for kidney disease could be
compared directly, but also illustrated the results with
categorical analyses.
Of the 20,431 individuals included in HBCS, 1,336
(6.5%) migrated away from Finland before any CKD,
6,116 (29.9%) died of other causes before any CKD, 375
(1.8%) had CKD hospitalization or death (for 14, the CKD
death had no prior CKD hospitalization), and 12,604 were
still alive at the end of follow-up in 2011, without having
migrated or had CKD.
The Ethics Committee at the National Public Health
Institute in Helsinki approved the study. Data were linked
by permission from the Ministry of Health and Social Af-
fairs, National Institute for Health and Welfare, and Sta-
tistics Finland. This is a register-based study and therefore
informed consent is not needed.Results
Table 1 shows descriptive data for neonatal measurements
and socioeconomic characteristics in the study cohorts. It
also summarizes the number of individuals identified with
CKD in 4 subgroups of kidney disease and their age at
onset. There were 226 (2.1%) men and 149 (1.5%)
women who had CKD diagnosed, with median ages of first
diagnosis at 64.3 and 64.9 years, respectively. We defined
CKD and its subtypes using the ICD codes shown in
Table S1. Of 375 people with CKD diagnosed, the sub-
groups are hypertensive kidney disease (n = 54; 14%),
diabetic kidney disease (n = 60; 16%), chronic kidney
failure (n = 126; 34%), and other, including nephritis
(n = 135; 36%).
Father’s occupational status was not associated with
CKD. Relative to offspring of manual worker fathers, HRs
for the other categories are 0.96 (95% confidence interval
[CI], 0.63-1.45) for those with fathers having upper-
middle-class occupations, 0.77 (95% CI, 0.56-1.07) for
those with fathers having lower-middle-class occupations,
and 1.08 (95% CI, 0.73-1.58) for unspecified. However,
individuals who themselves attained lower occupational21
Table 1. Descriptive Data for Study Population by Sex
Characteristic
Men (n = 10,614) Women (n = 9,817)
No. Missing Value No. Missing Value
Neonatal measurement
Weight, g 0 3,459 ± 497 0 3,332 ± 472
Length, cm 73 50.4 ± 1.9 72 49.8 ± 1.9
Head circumference, cm 83 35.2 ± 1.5 77 34.5 ± 1.4
Ponderal index, kg/m3 73 26.8 ± 2.4 72 26.8 ± 2.3
Gestational age, wk 613 39.6 ± 1.8 512 39.8 ± 1.8
Placental weight, g 27 645 ± 123 18 635 ± 121
Father’s occupation type
Upper middle class 949 (8.9%) 795 (8.1%)
Lower middle class 1,809 (17.0%) 1,714 (17.5%)
Manual worker 7,148 (67.3%) 6,616 (67.4%)
Unspecified 708 (6.7%) 692 (7.0%)
Adult occupation type
Upper middle class 1,992 (18.8%) 1,343 (13.7%)
Lower middle class 2,380 (22.4%) 4,882 (49.7%)
Self-employed 950 (9.0%) 666 (6.8%)
Manual worker 4,496 (42.4%) 2,128 (21.7%)
Unspecified 796 (7.5%) 798 (8.1%)
Cases of kidney disease
Any kidney disease 226 (2.1%) 149 (1.5%)
Hypertensive 34 (15.0%)a 20 (13.4%)a
Diabetic 45 (19.9%)a 15 (10.1%)a
Chronic kidney failure 75 (33.2%)a 51 (34.2%)a
Other, including nephritis 72 (31.9%)a 63 (42.3%)a
Median age at kidney disease, y 64.3 [54.2-71.9] 64.9 [50.8-73.6]
Note: Unless otherwise indicated, values are given as mean ± standard deviation, median [interquartile range], or number (percentage).
Abbreviations: Q1, lower quartile; Q3, upper quartile.
aUnless otherwise indicated, the denominator for calculating the percentage of each kidney disease subtype is the total number of individuals who had kidney disease.
Original Investigationstatus had higher rates of CKD. Again, relative to manual
workers, HRs for the other categories of the individual’s
own adult occupation are 0.71 (95% CI, 0.53-0.96) for
upper-middle-class occupation, 0.74 (95% CI, 0.57-0.96)
for lower-middle-class occupation, 0.51 (95% CI, 0.31-
0.83) for the self-employed, and 1.39 (95% CI, 0.83-
2.35) for unspecified.
Table 2 shows HRs for neonatal measurements and
CKD. Every additional standard deviation of birth weight is
associated with an HR for CKD of 0.82 (95% CI, 0.74-
0.91; P < 0.001). Associations with ponderal index,Table 2. Association of Neonatal Measurements and Chronic Kid
Neonatal Measurementa
Men and Women Men
HR (95% CI) P HR (95%
Birth weight 0.82 (0.74-0.91) <0.001 0.73 (0.
Birth length 0.88 (0.79-0.97) 0.01 0.81 (0.
Head circumference 0.93 (0.84-1.03) 0.2 0.91 (0.
Ponderal index 0.86 (0.77-0.95) 0.003 0.78 (0.
Gestational age 0.99 (0.89-1.10) 0.8 0.95 (0.
Placental weight 0.86 (0.78-0.95) 0.004 0.78 (0.
Note: The Cox model is stratified on combinations of sex and year of birth and also i
Abbreviations: CI, confidence interval; HR, hazard ratio.
aStandardized units.
22placental weight, and birth length are also statistically
significant, although not those with head circumference or
gestational age. These associations are confined to men.
Interaction tests (the product of sex and the neonatal
variable) suggest statistically significant differences in the
effect size in men and women for birth weight, ponderal
index, and placental weight (P for interaction values of
0.006, 0.03, and 0.03, respectively).
Tables 3 and S2 show further exploration of the asso-
ciation between CKD and birth weight. The association in
men and women is nominally stronger at age younger thanney Disease
Women
P for InteractionCI) P HR (95% CI) P
64-0.83) <0.001 0.99 (0.84-1.16) 0.9 0.004
71-0.93) 0.002 0.99 (0.84-1.17) 0.9 0.07
80-1.05) 0.2 0.95 (0.81-1.12) 0.6 0.7
68-0.89) <0.001 0.99 (0.84-1.17) 0.9 0.02
83-1.09) 0.4 1.05 (0.89-1.24) 0.6 0.4
69-0.90) <0.001 1.00 (0.85-1.17) 0.9 0.03
ncludes early life and adult socioeconomic status.
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Table 3. Further Exploration of Association Between Birth Weight and Chronic Kidney Disease
Men and Women Men Women
HR (95% CI) P HR (95% CI) P HR (95% CI) P
All kidney disease 0.82 (0.74-0.91) <0.001 0.73 (0.64-0.83) <0.001 0.99 (0.84-1.16) 0.9
Age at kidney disease
≤60 y 0.76 (0.64-0.89) <0.001 0.67 (0.54-0.83) <0.001 0.91 (0.70-1.18) 0.5
>60 y 0.87 (0.76-0.99) 0.03 0.77 (0.65-0.91) 0.002 1.05 (0.85-1.29) 0.7
Cause of kidney disease
Hypertensive 0.63 (0.48-0.82) <0.001 0.57 (0.40-0.80) 0.001 0.75 (0.48-1.16) 0.2
Diabetic 0.77 (0.60-0.99) 0.04 0.69 (0.51-0.93) 0.01 1.08 (0.65-1.81) 0.8
Chronic kidney failure 0.83 (0.69-0.99) 0.03 0.71 (0.57-0.90) 0.004 1.03 (0.78-1.36) 0.8
Other, including nephritis 0.95 (0.80-1.12) 0.5 0.87 (0.69-1.10) 0.3 1.04 (0.81-1.33) 0.8
Note: Birth weight is measured in standardized units. The Cox model is stratified on combinations of sex and year of birth and also includes early life and adult socio-
economic status. P values for the difference in effect size between those up to age 60 years and those older than 60 years were 0.20 (men and women), 0.31 (men), and
0.41 (women). Similarly, P values for difference in effect size according to subcause were 0.08 (men and women), 0.21 (men), and 0.60 (women).
Abbreviations: CI, confidence interval; HR, hazard ratio.
Original Investigation60 years than at older ages, but not statistically significantly
(P = 0.2). It is also nominally stronger for hypertensive
kidney disease than for the other causes group, but again
not statistically significantly (P = 0.08). Table S1 provides
equivalent results for the other 5 neonatal measurements.
Table 4 also includes data for gestational age in groups.
Although there is no linear trend across the groups, in-
dividuals who were born preterm (at gestational
week < 34) have higher rates of CKD. This was only
statistically significant among women. Table S3 shows
incidence rates of CKD in the study population.
Table 4 illustrates the results, presenting birth weight in
categories, and shows the continuous reduction in risk for
men associated with greater weight at birth. The pattern is
less clear for women, although it is the lightest 2 groups
that have the greatest HRs.
Using an equivalent approach, 3,265 (16%) of the
20,431 individuals were found to have been hospitalizedTable 4. Association of Birth Weight and Gestational Age With C








≤2.50 21/26 82 1.3 (0.8-2.1) 10/1
2.51-3.00 76/112 68 1.2 (0.9-1.6) 46/4
3.01-3.50 149/273 55 1.0 (reference) 101/1
3.51-4.00 105/209 50 0.9 (0.7-1.2) 56/1
>4.00 24/65 37 0.6 (0.4-1.0) 13/4
Gestational age at delivery
<34 completed wk 12/6 188 2.6 (1.4-4.6) 6/3
34-36 completed wk 26/38 68 1.0 (0.7-1.6) 19/2
37-38 completed wk 55/128 43 0.7 (0.5-1.0) 39/6
39-40 completed wk 173/322 54 1.0 (reference) 99/1
≥41 completed wk 79/152 52 1.0 (0.8-1.3) 43/7
Unknown 30/37 82 1.4 (0.9-2.0) 20/1
Note: The Cox model is stratified on combinations of sex and year of birth and also i
Abbreviations: CI, confidence interval; HR, hazard ratio.
aPerson-years of exposure in 1,000s.
bRate is per 100,000 person-years.
AJKD Vol 71 | Iss 1 | January 2018or have died of coronary heart disease during follow-up;
139 (37%) of the 375 individuals with CKD overlapped
with this group. Among those with no coronary heart
disease, the HR for CKD disease was 0.87 (95% CI, 0.77-
0.99) per additional standardized unit of birth weight
(P = 0.04), and among those with coronary heart disease,
it was similar at 0.79 (95% CI, 0.66-0.93) per additional
standardized unit of birth weight (P = 0.005).Discussion
We observed that small body size at birth is associated with
increased risk for developing CKD. This finding was not
confined to low birth weight only, but was also observed
for other markers of intrauterine growth restriction. Our
findings in relation to the association between small body
size at birth and CKD were confined to men. Prematurity










2 87 1.0 (0.5-1.9) 11/14 78 1.9 (1.0 to 3.7)
7 99 1.3 (0.9-1.8) 30/65 46 1.3 (0.8 to 2.1)
29 78 1.0 (reference) 48/144 33 1.0 (reference)
16 48 0.6 (0.5-0.9) 49/93 53 1.6 (1.1 to 2.4)
2 31 0.4 (0.2-0.7) 11/23 48 1.4 (0.8 to 2.8)
179 2.1 (0.9-4.9) 6/3 199 3.2 (1.4 to 7.4)
0 95 1.3 (0.8-2.2) 7/18 38 0.7 (0.3 to 1.4)
7 58 0.9 (0.6-1.3) 16/61 26 0.5 (0.3 to 0.9)
61 62 1.0 (reference) 74/161 46 1.0 (reference)
4 58 1.0 (0.7-1.4) 36/78 46 1.1 (0.7 to 1.6)
9 103 1.6 (1.0-2.7) 10/17 58 1.1 (0.6 to 2.1)
ncludes early life and adult socioeconomic status.
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Original Investigationfindings support the importance of early-life factors in the
development of CKD.
According to the DOHaD hypothesis, several non-
communicable diseases, including coronary heart disease
and hypertension, have their origins in early life.4-9 The
programming impact of early-life and childhood factors on
organ development and long-term function has been
shown in several other diseases, including CKD. Brenner
et al11 have proposed that the process of developmental
programming in the kidneys may result in a reduced
nephron number. This reduction in nephrons in the kid-
neys could contribute to the development of elevated
blood pressure and consequently increased risk for CKD.11
This hypothesis offers a plausible link between low birth
weight, hypertension, and CKD. Low birth weight and
being born small for gestational age are associated with a
low nephron number.20-23 Our present findings support
the hypothesis because there is a continuous reduction in
risk for CKD with greater birth weight among men. Not
only birth weight but also other markers of nonoptimal
prenatal growth, including birth length, ponderal index,
and placental weight, showed similar associations with
CKD in adult life. We did not observe similar associations
in women. These findings are similar to those reported
from a large Norwegian register-based cohort study.24
There have been several studies describing the associa-
tion between small body size at birth and different in-
dicators of kidney disease. These outcomes have included
measures of urinary albumin excretion rate, estimated
glomerular filtration rate, and end-stage renal disease
(ESRD).24-27 A systematic review that included more than
2 million individuals from 32 studies reported that low
birth weight confers a 70% increased risk for developing
CKD (defined as albuminuria, reduced glomerular filtra-
tion rate, or end-stage kidney failure [ESRD]) in later life
compared to normal birth weight.13 However, most
studies included in the systematic review were small and
follow-up of the individuals ended in early midlife. The
largest study included in the systematic review was based
on a register study from Norway, comprising all patients
born after 1967, when the Medical Birth Registry was
initiated, and who had developed ESRD in Norway since
1980. The authors concluded that low birth weight was
more strongly associated with ESRD development during
the first 14 years of life.24 However, the maximum follow-
up was 38 years. In our study, we followed up people in
the HBCS with a maximum follow-up of 86 years, which
to our knowledge is the longest follow-up reported in the
literature pertaining to early programming of CKD.
Low socioeconomic status (SES) is associated with
increased risk for cardiovascular morbidity and mortal-
ity.28,29 Similar associations have been reported between
SES and CKD, although the specific role of socioeconomic
factors at different stages of the life course remains
obscure.30 In high-income countries, CKD is most preva-
lent in people from lower socioeconomic groups. How-
ever, these associations have not been replicated in all24populations.31 A similar association has also been reported
in relation to low birth weight, hypertension, and CKD.32
In the present study, we assessed SES throughout the life
course. Childhood SES was not associated with CKD.
However, adult SES showed an inverse association with
CKD; higher SES was associated with significantly lower
risk for developing CKD. Factors explaining this association
may be environmental and infectious causes and inequities
in health care.33
Globally, w10% of infants are born preterm. We found
that individuals born preterm before 34 weeks of gestation
had an increased risk for CKD. Contrary to the risk associ-
ated with low birth weight, this risk was not confined to
men; it appeared stronger among women. Although pre-
term birth is a major risk factor for neonatal acute kidney
injury, the risk for manifest CKD surprisingly has been little
studied.23 Circumstantial evidence is provided by studies of
lower glomerular filtration rate in prepubertal children
born before 30 weeks or <1,000 g, smaller kidney volume
in young adults born before 32 weeks or <1,500 g, and a
case series of 6 adults with focal segmental glomerulo-
sclerosis whowere born before 30weeks gestation and now
aged 15 to 53 years.34-36 To our knowledge, our study is the
first to demonstrate that these findings translate to actual
increased risk for CKD in adults born preterm.
Although not all individuals with a low nephron
number develop CKD, low nephron number is an
important predisposing factor to CKD. A kidney with
fewer nephrons may be more vulnerable and therefore less
able to withstand additional “hits” later in life imposed by
nonoptimal growth, as well as conditions such as diabetes,
cardiovascular disease, and obesity.5,23,37
The term CKD is used to indicate a chronic irreversible
loss of kidney function, a process usually taking place
gradually over many years. Main risk factors for CKD
include hypertension and diabetes, and cardiovascular
comorbid conditions are common among people with
CKD.38 In the present study, w37% of the people with
CKD in our cohort had been hospitalized or died of cor-
onary heart disease. However, a similar association be-
tween birth weight and CKD persisted after excluding
those with simultaneous coronary heart disease.
Our findings were mostly restricted to men. However,
it is well known that pregnancies are more likely to have
nonoptimal outcomes with male offspring.39 This is
believed to be because boys grow faster than girls. This
more rapid growth takes place from an early stage of
gestation and consequently makes boys more vulnerable if
nutrition is compromised. We have previously shown that
boys are not only more vulnerable to undernutrition
during prenatal life than girls, but they also have a
different path of intrauterine growth, which could make
them respond differently in terms of maternal nutrition.
We have shown that different markers of maternal nutri-
tion program hypertension differently in the 2 sexes.40
Our study has some limitations. The data in the HBCS
are restricted to people who were both born in Helsinki inAJKD Vol 71 | Iss 1 | January 2018
Original Investigation1924 to 1944 in 1 of the 2 major maternity hospitals and
alive in 1971 (the year all Finnish residents were assigned
a unique identification number). Thus, our study partici-
pants may not be representative of all people in Helsinki.
For example, we lack information about people who were
born at home and at private clinics or who died or
emigrated before 1971. Thus, our study potentially has a
different distribution of socioeconomic groups than the
entire population of Helsinki at the time. However, as we
have previously reported, this cohort had a similar social
class distribution during childhood compared with that of
the city as a whole. People hospitalized before 1971 or
those who died before 1971 are not included in the ana-
lyses. However, this is a small part of the study population
because CKD rapidly increases with increasing age.
Furthermore, the HR with birth weight is very similar in
all age groups. Therefore, we do not believe this will in-
fluence our findings.
Furthermore, body size at birth is a crude measure of
the intrauterine environment, but it has been widely
used in the literature as a marker of prenatal develop-
ment. Among men, the relationship between birth size
and CKD was independent of length of gestation, which
suggests that it can be attributed to slow fetal growth
instead of preterm birth. Finally, we cannot determine
the extent to which the associations between thinness at
birth and CKD are mediated through other CKD risk
factors because we do not have these data available.
Another limitation of the study is lack of dietary infor-
mation for the cohort.
Strengths of our study include a well-characterized
sample with information for birth anthropometrics
collected from birth records and a long follow-up span-
ning to old age. Further strengths include reliable hospital
birth record−based information for maternal characteris-
tics and register-based information for CKD. The validity
of national hospital discharge and mortality registers has
been established.41 Register data for hospital admission
and discharge data were available for almost all cohort
members who had not migrated or died without hospital
in-patient care, thus minimizing loss to follow-up.
Moreover, the study cohort has been followed up for a
long period; follow-up time extends up to 86 years. The
study population is ethnically homogeneous, which is
both a strength and a weakness. Few studies have been able
simultaneously to assess the association of body size at
birth and later risk for CKD.
We conclude that small body size at birth is associated
with increased risk for developing CKD in men. Among
women, prematurity also increases the risk for CKD. These
findings support the importance of early-life factors in the
development of CKD.Supplementary Material
Table S1: Definition of kidney disease used in analyses according to
ICD revision in force.AJKD Vol 71 | Iss 1 | January 2018Table S2: Further exploration of association between neonatal
measurements and CKD.
Table S3: Incidence rates of CKD according to age, in men and
women combined and separately.
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